|
1
|
Haustein UF: Systemic
sclerosis-scleroderma. Dermatol Online J. 8(3)2002.PubMed/NCBI
|
|
2
|
Juche A, Siegert E, Mueller-Ladner U,
Riemekesten G, Günther C, Kötter I, Henes J, Blank N, Voll RE,
Ehrchen J, et al: Reality of inpatient vasoactive treatment with
prostacyclin derivatives in patients with acral circulation
disorders due to systemic sclerosis in Germany. Z Rheumatol.
79:1057–1066. 2020.PubMed/NCBI View Article : Google Scholar : (In German).
|
|
3
|
Bobeica C, Niculet E, Craescu M, Halip AI,
Popescu IA, Draganescu ML, Onisor C, Stefanescu B and
Gheuca-Solovastru L: Etiological factors of systemic sclerosis in
the southeast region of Romania. Exp Ther Med.
21(79)2021.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Gheorghe I, Tatu AL, Lupu I, Thamer O,
Cotar AI, Pircalabioru GG, Popa M, Cristea VC, Lazar V and
Chifiriuc MC: Molecular characterization of virulence and
resistance features in Staphylococcus aureus clinical strains
isolated from cutaneous lesions in patients with drug adverse
reactions. Rom Biotechnol Lett. 22:12321–12327. 2017.
|
|
5
|
Tatu AL and Cristea VC: Unilateral
blepharitis with fine follicular scaling. J Cutan Med Surg.
21(442)2017.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Horodinschi RN, Stanescu AMA, Bratu OG,
Pantea Stoian A, Radavoi DG and Diaconu CC: Treatment with statines
in elderly patients. Medicina (Kaunas). 55(721)2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Tatu AL and Nwabudike LC: Reply to: Kubiak
K et al. Endosymbiosis and its significance in dermatology.
J Eur Acad Dermatol Venereol. 32:e346–e347. 2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Gheorghe G, Toth PP, Bungau S, Behl T,
Ilie M, Pantea Stoian A, Bratu OG, Bacalbasa N, Rus M and Diaconu
CC: Cardiovascular risk and statin therapy considerations in women.
Diagnostics (Basel). 10(483)2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Bobeică C, Tatu AL, Crăescu M and
Solovăstru L: Dinamics of digital ulcers in systemic sclerosis. Exp
Ther Med. 20:61–67. 2020.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Mazilu L, Stanculescu DL, Gheorghe AD,
Suceveanu AP, Parepa IR, Stoian AP, Pop CS, Bratu O and Suceveanu
AI: Chemotherapy and other factors affecting quality of life in
non-small cell lung cancer (NSCLC) patients. Rev Chim. 70:33–35.
2019.
|
|
11
|
Nwabudike LC and Tatu AL: Magistral
prescription with silver nitrate and peru balsam in
difficult-to-heal diabetic foot ulcers. Am J Ther. 25:e679–e680.
2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Tatu AL, Clatici VG and Nwabudike LC:
Rosacea-like demodicosis (but not primary demodicosis) and
papulopustular rosacea may be two phenotypes of the same disease-a
microbioma, therapeutic and diagnostic tools perspective. J Eur
Acad Dermatol Venereol. 33:e46–e47. 2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Crismaru I, Pantea Stoian A, Bratu OG,
Gaman MA, Stanescu AMA, Bacalbasa N and Diaconu CC: Low-density
lipoprotein cholesterol lowering treatment: The current approach.
Lipids Health Dis. 19(85)2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Tatu AL, Elisei AM, Chioncel V, Miulescu M
and Nwabudike LC: Immunologic adverse reactions of β-blockers and
the skin. Exp Ther Med. 18:955–959. 2019.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Buzia OD, Fasie V, Mardare N, Diaconu C,
Gurau G and Tatu AL: Formulation, preparation, physico-chimical
analysis, microbiological peculiarities and therapeutic challenges
of extractive solution of Kombucha. Rev Chim. 69:720–724. 2018.
|
|
16
|
Tatu AL, Ionescu MA and Nwabudike LC:
Contact allergy to topical mometasone furoate confirmed by
rechallenge and patch test. Am J Ther. 25:e497–e498.
2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Nwabudike LC, Miulescu M and Tatu AL: Case
series of an alternative therapy for generalised lichen planus:
Four case studies. Exp Ther Med. 18:943–948. 2019.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Jacobsen S, Halberg P, Ullman S, Van
Venrooij WJ, Høier-Madsen M, Wiik A and Petersen J: Clinical
features and serum antinuclear antibodies in 230 Danish patients
with systemic sclerosis. Br J Rheumatol. 37:39–45. 1998.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Fabri M and Hunzelmann N: Differential
diagnosis of scleroderma and pseudoscleroderma. J Dtsch Dermatol
Ges. 5:977–984. 2007.PubMed/NCBI View Article : Google Scholar : (In English,
German).
|
|
20
|
Steen VD, Powell DL and Medsger TA Jr:
Clinical correlations and prognosis based on serum autoantibodies
in patients with systemic sclerosis. Arthritis Rheum. 31:196–203.
1988.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Bobeica C, Niculet E, Craescu M, Onisor C,
Bujoreanu F, Draganescu ML, Halip IA and Gheuca-Solovastru L:
Epidemiological profile of systemic sclerosis in the southeast
region of Romania. Exp Ther Med. 21(77)2021.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Monfort JB, Mathian A, Amoura Z, Francès
C, Barbaud A and Senet P: Cancers associated with systemic
sclerosis involving anti-RNA polymerase III antibodies. Ann
Dermatol Venereol. 145:33–36. 2018.PubMed/NCBI View Article : Google Scholar : (In French).
|
|
23
|
Monfort JB, Lazareth I and Priollet P:
Paraneoplastic systemic sclerosis: About 3 cases and review of
literature. J Mal Vasc. 41:365–370. 2016.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Nwabudike LC and Tatu AL: Response
to-chronic exposure to tetracyclines and subsequent diagnosis for
non-melanoma skin cancer in a large Mid-Western US population. J
Eur Acad Dermatol Venereol. 32(e159)2018.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Tatu AL and Nwabudike LC: The treatment
options of male genital lichen sclerosus et atrophicus short title
for a running head: Treatments of genital lichen sclerosus
conference: 14th National Congress of Urogynecology (Urogyn)
Location: Eforie, Romania Date: SEP 07-09, 2017. Proceedings of the
14th National Congress of Urogynecology and the National Conference
of the Romania Association for the Study of Pain, pp262-264,
2017.
|
|
26
|
Nwabudike LC, Elisei AM, Buzia OD,
Miulescu M and Tatu AL: Statins. A review on structural
perspectives, adverse reactions and relations with son-melanoma
skin cancer. Rev Chim. 69:2557–2562. 2018.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Steen VD and Medsger TA Jr: The value of
the health assessment questionnaire and special patient-generated
scales to demonstrate change in systemic sclerosis patients over
time. Arthritis Rheum. 40:1984–1991. 1997.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Denton CP: Advances in pathogenesis and
treatment of systemic sclerosis. Clin Med (Lond). 16:55–60.
2016.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Masi AT and Medsger TA Jr: Progress in the
evolution of systemic sclerosis classification criteria and
recommendation for additional comparative specificity studies. J
Rheumatol. 42:8–10. 2015.PubMed/NCBI View Article : Google Scholar
|
|
30
|
LeRoy EC, Black C, Fleischmajer R,
Jablonska S, Krieg T, Medsger TA Jr, Rowell N and Wollheim F:
Scleroderma (systemic sclerosis): Classification, subsets and
pathogenesis. J Rheumatol. 15:202–205. 1988.PubMed/NCBI
|
